Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$484M |
| 2 |
Microsoft
MSFT
|
+$417M |
| 3 |
Amazon
AMZN
|
+$365M |
| 4 |
Apple
AAPL
|
+$357M |
| 5 |
Merck
MRK
|
+$311M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$420M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$288M |
| 3 |
Philip Morris
PM
|
+$246M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$228M |
| 5 |
Meta Platforms (Facebook)
META
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.14% |
| 2 | Healthcare | 13.96% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
UFP Technologies
UFPT
$2.43B
| $17.4M | ﹤0.01% |
133,861
+6,529
| +5% | +$759K |
|
|
ACLX
1902
DELISTED
Arcellx
ACLX
| $17.3M | ﹤0.01% |
561,604
+16,834
| +3% | +$511K |
|
1903
PAR Technology
PAR
$735M
| $17.2M | ﹤0.01% |
507,880
+24,802
| +5% | +$827K |
|
|
SPTN
1904
DELISTED
SpartanNash
SPTN
| $17.2M | ﹤0.01% |
694,227
+23,804
| +4% | +$686K |
|
1905
Protolabs
PRLB
$2.13B
| $17.2M | ﹤0.01% |
519,307
+24,751
| +5% | +$766K |
|
1906
Cytek Biosciences
CTKB
$546M
| $17.2M | ﹤0.01% |
1,869,470
+83,335
| +5% | +$896K |
|
1907
LegalZoom.com
LZ
$988M
| $17.2M | ﹤0.01% |
1,828,418
+61,729
| +3% | +$523K |
|
1908
First Advantage
FA
$4.12B
| $17.1M | ﹤0.01% |
1,227,121
+35,229
| +3% | +$478K |
|
|
PGRE
1909
DELISTED
Paramount Group
PGRE
| $17.1M | ﹤0.01% |
3,753,608
+124,064
| +3% | +$681K |
|
1910
Credo Technology Group
CRDO
$46.6B
| $17.1M | ﹤0.01% |
1,813,517
+88,271
| +5% | +$1.11M |
|
1911
International Money Express
IMXI
$367M
| $17.1M | ﹤0.01% |
661,799
+43,458
| +7% | +$1.05M |
|
|
SLCA
1912
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $17M | ﹤0.01% |
1,423,937
+66,144
| +5% | +$787K |
|
1913
Outset Medical
OM
$90.8M
| $16.9M | ﹤0.01% |
61,373
+2,341
| +4% | +$859K |
|
|
PACW
1914
DELISTED
PacWest Bancorp
PACW
| $16.9M | ﹤0.01% |
1,737,143
+46,301
| +3% | +$1.03M |
|
|
AMWD
1915
DELISTED
American Woodmark
AMWD
| $16.9M | ﹤0.01% |
324,360
+9,924
| +3% | +$537K |
|
1916
Procept Biorobotics
PRCT
$1.17B
| $16.9M | ﹤0.01% |
593,878
+32,645
| +6% | +$1.15M |
|
1917
Tompkins Financial
TMP
$1.42B
| $16.9M | ﹤0.01% |
254,611
+10,177
| +4% | +$749K |
|
1918
Compass
COMP
$9.66B
| $16.8M | ﹤0.01% |
5,210,878
+171,725
| +3% | +$589K |
|
1919
Gulfport Energy Corp
GPOR
$2.88B
| $16.8M | ﹤0.01% |
209,977
+9,443
| +5% | +$684K |
|
1920
iQIYI
IQ
$1.28B
| $16.8M | ﹤0.01% |
2,318,172
+440,664
| +23% | +$3.02M |
|
|
UMH
1921
UMH Properties
UMH
$1.36B
| $16.8M | ﹤0.01% |
1,134,700
+67,646
| +6% | +$1.11M |
|
1922
Levi Strauss
LEVI
$9.39B
| $16.8M | ﹤0.01% |
919,359
+19,885
| +2% | +$342K |
|
1923
N-able
NABL
$940M
| $16.7M | ﹤0.01% |
1,268,184
+58,191
| +5% | +$643K |
|
|
RC
1924
Ready Capital
RC
$308M
| $16.7M | ﹤0.01% |
1,645,673
+44,270
| +3% | +$518K |
|
1925
Twist Bioscience
TWST
$7.25B
| $16.7M | ﹤0.01% |
1,107,008
+48,982
| +5% | +$1.08M |
|
Similar funds
Geode Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Geode Capital Management held 4,968 positions worth $770B, up 8.1% from $713B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 4.6%. Geode Capital Management opened 69 new positions and exited 162, leaving the 4,968-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q1 2023 buy was GE HealthCare: 6,775,612 shares worth $554M.
- Geode Capital Management added most to Microsoft in Q1 2023, an estimated $417M increase.
- Geode Capital Management's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $420M.
- Geode Capital Management fully exited SVB Financial Group in Q1 2023, selling an estimated $288M.
- Geode Capital Management's ten largest holdings make up 23% of its $770B portfolio in Q1 2023.
- Geode Capital Management opened 69 new positions and closed 162 in Q1 2023.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $770B.
Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.